Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -5.94 is 141% below its 5-year average of 14.48, near the low end of its 5-year range (-5.94–49.94).
As of the fiscal period ended Wednesday, December 31, 2025. 45.49% below its 12-month average of -4.08.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 17 quarters.
EARNINGS PER SHARE (EPS)
-5.94
EARNINGS PER SHARE (EPS) AVG TTM
-4.08
EARNINGS PER SHARE (EPS) AVG 3Y
9.21
EARNINGS PER SHARE (EPS) AVG 5Y
14.48
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-45.49%
CURRENT VS 3Y AVG
-164.48%
CURRENT VS 5Y AVG
-141.03%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BioNTech SE
Market Cap
$22.91B
Earnings Per Share (EPS)
-5.94
TTM Avg
-4.08
3Y Avg
9.21
5Y Avg
14.48
Market Cap
$21.98B
Earnings Per Share (EPS)
27.05
TTM Avg
28.29
3Y Avg
23.40
5Y Avg
19.31
Market Cap
$24.00B
Earnings Per Share (EPS)
7.82
TTM Avg
6.79
3Y Avg
7.36
5Y Avg
7.17
Market Cap
$21.75B
Earnings Per Share (EPS)
-7.98
TTM Avg
-8.27
3Y Avg
-1.90
5Y Avg
3.46
Market Cap
$24.23B
Earnings Per Share (EPS)
7.85
TTM Avg
3.38
3Y Avg
2.74
5Y Avg
2.31
Market Cap
$24.59B
Earnings Per Share (EPS)
7.87
TTM Avg
10.78
3Y Avg
11.05
5Y Avg
10.65
Market Cap
$25.35B
Earnings Per Share (EPS)
12.09
TTM Avg
9.71
3Y Avg
9.57
5Y Avg
13.14
Market Cap
$20.45B
Earnings Per Share (EPS)
-0.26
TTM Avg
-1.77
3Y Avg
-0.44
5Y Avg
-0.66
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNTech SE (BNTX) | $22.91B | -5.94 | -4.08 | 9.21 | 14.48 |
| STERIS plc (STE)vs › | $22.26B | 7.93 | 7.08 | 4.77 | 4.37 |
| United Therapeutics Corporation (UTHR)vs › | $21.98B | 27.05 | 28.29 | 23.40 | 19.31 |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.00B | 7.82 | 6.79 | 7.36 | 7.17 |
| Moderna, Inc. (MRNA)vs › | $21.75B | -7.98 | -8.27 | -1.90 | 3.46 |
| Incyte Corporation (INCY)vs › | $24.23B | 7.85 | 3.38 | 2.74 | 2.31 |
| Waters Corporation (WAT)vs › | $24.59B | 7.87 | 10.78 | 11.05 | 10.65 |
| Labcorp Holdings Inc. (LH)vs › | $25.35B | 12.09 | 9.71 | 9.57 | 13.14 |
| Viatris Inc. (VTRS)vs › | $20.45B | -0.26 | -1.77 | -0.44 | -0.66 |
| Quest Diagnostics Incorporated (DGX)vs › | $25.72B | 9.42 | 8.33 | 8.09 | 9.83 |
Trailing EPS (TTM)
$-5.94
Forward EPS (Est.)
$-4.49
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -5.30 |
| 2024-12-31 | -2.87 |
| 2023-12-31 | 4.27 |
| 2022-12-31 | 40.74 |
| 2021-12-31 | 49.94 |
| 2020-12-31 | 0.07 |
| 2019-12-31 | -0.95 |
| 2018-12-31 | -0.24 |
| 2017-12-31 | -0.46 |
